CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-16 | Alenson Carman Principal Accounting Officer | Option exercise | +2,800 | 3,774 | ||
| 2020-02-16 | Alenson Carman Principal Accounting Officer | Option exercise · Restricted stock units | −790 | 790 | ||
| 2020-02-16 | Alenson Carman Principal Accounting Officer | Option exercise · Restricted stock units | −2,800 | 0 | ||
| 2020-02-16 | Bowden Christopher Chief Medical Officer | Option exercise | +2,750 | 4,400 | ||
| 2020-02-16 | Bowden Christopher Chief Medical Officer | Option exercise · Restricted stock unit | −2,750 | 2,750 | ||
| 2020-02-16 | Hirsch Andrew Chief Financial Officer | Option exercise | +2,750 | 15,127 | ||
| 2020-02-16 | Hirsch Andrew Chief Financial Officer | Option exercise · Restricted stock units | −2,750 | 2,750 | ||
| 2020-02-16 | Schenkein David P Director | Option exercise | +8,125 | 105,692 | ||
| 2020-02-16 | Schenkein David P Director | Option exercise · Restricted stock units | −8,125 | 8,125 | ||
| 2020-02-14 | MARAGANORE JOHN Director | Gift | −2,400 | 30,209 | ||
| 2020-02-14 | MARAGANORE JOHN Director | Gift | −1,915 | 28,294 | ||
| 2020-02-14 | Alenson Carman Principal Accounting Officer | Grant or award · Restricted stock units | +2,666 | 2,666 | ||
| 2020-02-14 | Alenson Carman Principal Accounting Officer | Grant or award · Restricted stock unit | +4,800 | 4,800 | ||
| 2020-02-14 | Alenson Carman Principal Accounting Officer | Grant or award · Stock option (right to buy) | +5,332 | 5,332 | ||
| 2020-02-14 | Bowden Christopher Chief Medical Officer | Grant or award · Restricted stock units | +12,000 | 12,000 | ||
| 2020-02-14 | Bowden Christopher Chief Medical Officer | Grant or award · Stock option (right to buy) | +45,000 | 45,000 | ||
| 2020-02-14 | FOUSE JACQUALYN A Chief Executive Officer | Grant or award · Stock option (right to buy) | +137,000 | 137,000 | ||
| 2020-02-14 | FOUSE JACQUALYN A Chief Executive Officer | Grant or award · Restricted stock units | +34,000 | 34,000 | ||
| 2020-02-14 | Hirsch Andrew Chief Financial Officer | Grant or award · Restricted stock units | +12,000 | 12,000 | ||
| 2020-02-14 | Hirsch Andrew Chief Financial Officer | Grant or award · Stock option (right to buy) | +45,000 | 45,000 |
Page 49 of 63 · 1,252 trades